|
|
Toll样受体在神经系统相关疾病中的研究进展
|
Abstract:
Toll样受体(TLRs)是一种I型跨膜蛋白，作为一种模式识别受体，可以诱导天然免疫。近年来，TLRs在神经系统相关疾病中的作用受到了人们广泛的关注，大量的研究表明，TLRs介导的神经炎症反应在脑血管疾病、神经退行性疾病以及中枢脱髓鞘疾病中有着重要的作用。故本文就其在几种较为典型的神经系统疾病中的研究进展做一综述，以期为相关领域研究提供参考。
Toll-like receptors (TLRs) are a type I transmembrane protein that acts as a pattern recognition receptor and can induce innate immunity. In recent years, the role of TLRs in nervous system-related diseases has received extensive attention. A large number of studies have shown that TLRs mediated neuroinflammatory response plays an important role in cerebrovascular diseases, neurodegenerative diseases and central demyelinating diseases. Therefore, this article reviews the research progress in several typical nervous system diseases in order to provide reference for the research in related fields.
| [1] | Wang, Y., Ge, P. and Zhu, Y. (2013) TLR2 and TLR4 in the Brain Injury Caused by Cerebral Ischemia and Reperfusion. Mediators of Inflammation, 2013, Article 124614. https://doi.org/10.1155/2013/124614 |
| [2] | Kumar, V. (2019) Toll-Like Receptors in the Pathogenesis of Neuroinflammation. Journal of Neuroimmunology, 332, 16-30. https://doi.org/10.1016/j.jneuroim.2019.03.012 |
| [3] | Heidari, A., Yazdanpanah, N. and Rezaei, N. (2022) The Role of Toll-Like Receptors and Neuroinflammation in Parkinson’s Disease. Journal of Neuroinflammation, 19, Article No. 135. https://doi.org/10.1186/s12974-022-02496-w |
| [4] | Deng, S., Chen, X., Lei, Q. and Lu, W. (2022) AQP2 Promotes Astrocyte Activation by Modulating the TLR4/NfκB-p65 Pathway Following Intracerebral Hemorrhage. Frontiers in Immunology, 13, Article 847360. https://doi.org/10.3389/fimmu.2022.847360 |
| [5] | Adhikarla, S.V., Jha, N.K., Goswami, V.K., Sharma, A., Bhardwaj, A., Dey, A., et al. (2021) TLR-Mediated Signal Transduction and Neurodegenerative Disorders. Brain Sciences, 11, Article 1373. https://doi.org/10.3390/brainsci11111373 |
| [6] | Anderson, K.V., Bokla, L. and Nüsslein-Volhard, C. (1985) Establishment of Dorsal-Ventral Polarity in the Drosophila Embryo: The Induction of Polarity by the Toll Gene Product. Cell, 42, 791-798. https://doi.org/10.1016/0092-8674(85)90275-2 |
| [7] | Medzhitov, R., Preston-Hurlburt, P. and Janeway, C.A. (1997) A Human Homologue of the Drosophila Toll Protein Signals Activation of Adaptive Immunity. Nature, 388, 394-397. https://doi.org/10.1038/41131 |
| [8] | Fitzgerald, K.A. and Kagan, J.C. (2020) Toll-Like Receptors and the Control of Immunity. Cell, 180, 1044-1066. https://doi.org/10.1016/j.cell.2020.02.041 |
| [9] | Kawai, T. and Akira, S. (2010) The Role of Pattern-Recognition Receptors in Innate Immunity: Update on Toll-Like Receptors. Nature Immunology, 11, 373-384. https://doi.org/10.1038/ni.1863 |
| [10] | 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 缺血性卒中基层诊疗指南(2021年) [J]. 中华全科医师杂志, 2021, 20(9): 927-946. |
| [11] | Feigin, V.L., Stark, B.A., Johnson, C.O., Roth, G.A., Bisignano, C., Abady, G.G., et al. (2021) Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 20, 795-820. https://doi.org/10.1016/s1474-4422(21)00252-0 |
| [12] | Feigin, V.L., Owolabi, M.O., Feigin, V.L., Abd-Allah, F., Akinyemi, R.O., Bhattacharjee, N.V., et al. (2023) Pragmatic Solutions to Reduce the Global Burden of Stroke: A World Stroke Organization-Lancet Neurology Commission. The Lancet Neurology, 22, 1160-1206. https://doi.org/10.1016/s1474-4422(23)00277-6 |
| [13] | 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性卒中诊治指南2023 [J]. 中华神经科杂志, 2024, 57(6): 523-559. |
| [14] | Pascual, M., Calvo‐Rodriguez, M., Núñez, L., Villalobos, C., Ureña, J. and Guerri, C. (2021) Toll‐Like Receptors in Neuroinflammation, Neurodegeneration, and Alcohol‐Induced Brain Damage. IUBMB Life, 73, 900-915. https://doi.org/10.1002/iub.2510 |
| [15] | Amini, H., Knepp, B., Rodriguez, F., Jickling, G.C., Hull, H., Carmona-Mora, P., et al. (2023) Early Peripheral Blood Gene Expression Associated with Good and Poor 90-Day Ischemic Stroke Outcomes. Journal of Neuroinflammation, 20, Article No. 13. https://doi.org/10.1186/s12974-022-02680-y |
| [16] | Jiang, H., Sun, Z., Zhu, X., Li, F. and Chen, Q. (2023) Essential Genes Ptgs2, Tlr4, and Ccr2 Regulate Neuro-Inflammation during the Acute Phase of Cerebral Ischemic in Mice. Scientific Reports, 13, Article No. 13021. https://doi.org/10.1038/s41598-023-40255-w |
| [17] | Yao, X., Liu, S., Ding, W., Yue, P., Jiang, Q., Zhao, M., et al. (2017) TLR4 Signal Ablation Attenuated Neurological Deficits by Regulating Microglial M1/M2 Phenotype after Traumatic Brain Injury in Mice. Journal of Neuroimmunology, 310, 38-45. https://doi.org/10.1016/j.jneuroim.2017.06.006 |
| [18] | 黄红丽, 陈建, 王化强, 等. 急性脑梗死患者血浆高迁移率族蛋白B1/Toll样受体4变化及其与脑梗死体积、神经功能缺损及预后的关系[J]. 国际神经病学神经外科学杂志, 2022, 49(2): 15-19. |
| [19] | Fernández, G., Moraga, A., Cuartero, M.I., García-Culebras, A., Peña-Martínez, C., Pradillo, J.M., et al. (2018) TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models. Molecular Therapy, 26, 2047-2059. https://doi.org/10.1016/j.ymthe.2018.05.019 |
| [20] | Hernández-Jiménez, M., Abad-Santos, F., Cotgreave, I., Gallego, J., Jilma, B., Flores, A., et al. (2023) Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment. JAMA Neurology, 80, 779-788. https://doi.org/10.1001/jamaneurol.2023.1660 |
| [21] | Sansing, L.H., Harris, T.H., Welsh, F.A., Kasner, S.E., Hunter, C.A. and Kariko, K. (2011) Toll‐Like Receptor 4 Contributes to Poor Outcome after Intracerebral Hemorrhage. Annals of Neurology, 70, 646-656. https://doi.org/10.1002/ana.22528 |
| [22] | Fei, X., He, Y., Chen, J., Man, W., Chen, C., Sun, K., et al. (2019) The Role of Toll-Like Receptor 4 in Apoptosis of Brain Tissue after Induction of Intracerebral Hemorrhage. Journal of Neuroinflammation, 16, Article No. 234. https://doi.org/10.1186/s12974-019-1634-x |
| [23] | Longa, E.Z., Weinstein, P.R., Carlson, S. and Cummins, R. (1989) Reversible Middle Cerebral Artery Occlusion without Craniectomy in Rats. Stroke, 20, 84-91. https://doi.org/10.1161/01.str.20.1.84 |
| [24] | Mitsui, K., Ikedo, T., Kamio, Y., Furukawa, H., Lawton, M.T. and Hashimoto, T. (2020) TLR4 (Toll-Like Receptor 4) Mediates the Development of Intracranial Aneurysm Rupture. Hypertension, 75, 468-476. https://doi.org/10.1161/hypertensionaha.118.12595 |
| [25] | Okada, T., Kawakita, F., Nishikawa, H., Nakano, F., Liu, L. and Suzuki, H. (2018) Selective Toll-Like Receptor 4 Antagonists Prevent Acute Blood-Brain Barrier Disruption after Subarachnoid Hemorrhage in Mice. Molecular Neurobiology, 56, 976-985. https://doi.org/10.1007/s12035-018-1145-2 |
| [26] | Ma, C., Zhou, W., Yan, Z., Qu, M. and Bu, X. (2015) Toll-Like Receptor 4 (TLR4) Is Correlated with Delayed Cerebral Ischemia (DCI) and Poor Prognosis in Aneurysmal Subarachnoid Hemorrhage. Journal of the Neurological Sciences, 359, 67-71. https://doi.org/10.1016/j.jns.2015.10.018 |
| [27] | 中华医学会神经病学分会帕金森病及运动障碍学组, 中国医师协会神经内科医师分会帕金森病及运动障碍学组. 中国帕金森病治疗指南(第四版) [J]. 中华神经科杂志, 2020, 53(12): 973-986. |
| [28] | Zeng, X., Geng, W., Jia, J., Chen, L. and Zhang, P. (2018) Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease. Frontiers in Aging Neuroscience, 10, Article 109. https://doi.org/10.3389/fnagi.2018.00109 |
| [29] | Tolosa, E., Garrido, A., Scholz, S.W. and Poewe, W. (2021) Challenges in the Diagnosis of Parkinson’s Disease. The Lancet Neurology, 20, 385-397. https://doi.org/10.1016/s1474-4422(21)00030-2 |
| [30] | Zheng, Z., Zhu, Z., Zhou, C., Cao, L. and Zhao, G. (2022) Burden of Parkinson Disease in China, 1990-2019: Findings from the 2019 Global Burden of Disease Study. Neuroepidemiology, 57, 51-64. https://doi.org/10.1159/000527372 |
| [31] | Kouli, A., Horne, C.B. and Williams-Gray, C.H. (2019) Toll-Like Receptors and Their Therapeutic Potential in Parkinson’s Disease and α-Synucleinopathies. Brain, Behavior, and Immunity, 81, 41-51. https://doi.org/10.1016/j.bbi.2019.06.042 |
| [32] | Kin, K., Yasuhara, T., Kameda, M. and Date, I. (2019) Animal Models for Parkinson’s Disease Research: Trends in the 2000s. International Journal of Molecular Sciences, 20, Article 5402. https://doi.org/10.3390/ijms20215402 |
| [33] | He, Y., Zhao, J., Dong, H., Zhang, X., Duan, Y., Ma, Y., et al. (2023) TLR2 Deficiency Is Beneficial at the Late Phase in MPTP-Induced Parkinson’ Disease Mice. Life Sciences, 333, Article 122171. https://doi.org/10.1016/j.lfs.2023.122171 |
| [34] | Zhang, Z., Liu, Z., Lv, A. and Fan, C. (2023) How Toll-Like Receptors Influence Parkinson’s Disease in the Microbiome-Gut-Brain Axis. Frontiers in Immunology, 14, Article 1154626. https://doi.org/10.3389/fimmu.2023.1154626 |
| [35] | Zhao, Z., Ning, J., Bao, X., Shang, M., Ma, J., Li, G., et al. (2021) Fecal Microbiota Transplantation Protects Rotenone-Induced Parkinson’s Disease Mice via Suppressing Inflammation Mediated by the Lipopolysaccharide-TLR4 Signaling Pathway through the Microbiota-Gut-Brain Axis. Microbiome, 9, Article No. 226. https://doi.org/10.1186/s40168-021-01107-9 |
| [36] | 郭清华, 郭彦杰, 宋净洋, 等. 帕金森病患者血清中Toll样受体4及下游炎症因子的高表达与临床分期及分型的关系研究[J]. 国际神经病学神经外科学杂志, 2022, 49(3): 41-45. |
| [37] | Dzamko, N., Gysbers, A., Perera, G., Bahar, A., Shankar, A., Gao, J., et al. (2016) Toll-Like Receptor 2 Is Increased in Neurons in Parkinson’s Disease Brain and May Contribute to Alpha-Synuclein Pathology. Acta Neuropathologica, 133, 303-319. https://doi.org/10.1007/s00401-016-1648-8 |
| [38] | 中华医学会神经病学分会神经免疫学组. 多发性硬化诊断与治疗中国指南(2023版) [J]. 中华神经科杂志, 2024, 57(1): 10-23. |
| [39] | Tian, D., Zhang, C., Yuan, M., Yang, X., Gu, H., Li, Z., et al. (2020) Incidence of Multiple Sclerosis in China: A Nationwide Hospital-Based Study. The Lancet Regional Health-Western Pacific, 1, Article 100010. https://doi.org/10.1016/j.lanwpc.2020.100010 |
| [40] | 赵培源, 陈少昀, 刘喜红, 等. 多发性硬化实验动物模型的研究与应用进展[J]. 中国实验动物学报, 2020, 28(3): 405-409. |
| [41] | 韩晶晶, 张英, 姚瑞芹, 等. 敲除Toll样受体4基因对小鼠实验性自身免疫性脑脊髓炎的影响[J]. 神经解剖学杂志, 2022, 38(3): 287-292. |
| [42] | Shao, W., Huang, Y., Wang, L., Li, P., Jia, Y. and Zhang, J. (2023) Expression of Fibrinogen-Like Protein 2 (Fgl2) on Toll-Like Receptor 9 (TLR9) Expression in Autoimmune Myelitis. International Immunopharmacology, 114, Article 109539. https://doi.org/10.1016/j.intimp.2022.109539 |
| [43] | Mustafa, A.M., Shaheen, A.M., Zaki, H.F. and Rabie, M.A. (2024) Nicorandil and Carvedilol Mitigates Motor Deficits in Experimental Autoimmune Encephalomyelitis-Induced Multiple Sclerosis: Role of TLR4/TRAF6/MAPK/NF-κB Signalling Cascade. International Immunopharmacology, 127, Article 111387. https://doi.org/10.1016/j.intimp.2023.111387 |
| [44] | Hossain, M.J., Morandi, E., Tanasescu, R., Frakich, N., Caldano, M., Onion, D., et al. (2018) The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker. Frontiers in Immunology, 9, Article 457. https://doi.org/10.3389/fimmu.2018.00457 |
